Literature DB >> 24032630

Incorporation of CF3-pseudoprolines into peptides: a methodological study.

Grégory Chaume1, Julien Simon, Caroline Caupène, Nathalie Lensen, Emeric Miclet, Thierry Brigaud.   

Abstract

The peptide coupling reactions allowing the incorporation of trifluoromethyl substituted oxazolidine-type pseudoprolines (CF3-ΨPro) into peptide chains have been studied. While standard protocols can be used for the peptide coupling reaction at the C-terminal position of the CF3-ΨPro, acid chloride activation has to be used for the peptide coupling reaction at the N-terminal position to overcome the decrease of nucleophilicity of the CF3-ΨPro. We demonstrate that the N-amidification of a diastereomeric mixture of CF3-ΨPro using Fmoc-protected amino acid chloride without base gave the corresponding dipeptides as a single diastereomer (6 examples). The ratio of the cis and trans amide bond conformers was determined by NMR study, highlighting the role of the Xaa side chains in the control of the peptide backbone conformation. Finally a tripeptide bearing a central CF3-ΨPro has been successfully synthesized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24032630     DOI: 10.1021/jo401494q

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Stereoelectronic basis for the kinetic resolution of N-heterocycles with chiral acylating reagents.

Authors:  Sheng-Ying Hsieh; Benedikt Wanner; Philip Wheeler; André M Beauchemin; Tomislav Rovis; Jeffrey W Bode
Journal:  Chemistry       Date:  2014-05-18       Impact factor: 5.236

2.  Trifluoromethylated proline analogues as efficient tools to enhance the hydrophobicity and to promote passive diffusion transport of the l-prolyl-l-leucyl glycinamide (PLG) tripeptide.

Authors:  Martin Oliver; Charlène Gadais; Júlia García-Pindado; Meritxell Teixidó; Nathalie Lensen; Grégory Chaume; Thierry Brigaud
Journal:  RSC Adv       Date:  2018-04-18       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.